Oncological and functional outcomes after testis-sparing surgery in patients with germ cell tumors: a systematic review of 285 cases.
Josias Bastian GroggZeynep Hafza DursunJoerg BeyerDaniel EberliCedric PoyetThomas HermannsChristian Daniel FankhauserPublished in: World journal of urology (2022)
The current data questions the benefits of TSS in tGCT patients. If at all, TSS should only be offered to well-informed patients with a singular testicle, excellent compliance, a singular tumor less than 2 cm located at the lower pole of the testicle, and normal preoperative endocrine function. Unless patients plan to father a child within a short time frame, adjuvant testicular radiotherapy should be recommended after TSS. Radical orchiectomy remains the standard of care, but future studies may support the use of TSS in selected men.
Keyphrases
- end stage renal disease
- germ cell
- newly diagnosed
- ejection fraction
- early stage
- healthcare
- peritoneal dialysis
- radiation therapy
- minimally invasive
- prostate cancer
- electronic health record
- quality improvement
- patient reported outcomes
- coronary artery disease
- radiation induced
- chronic pain
- radical prostatectomy
- atrial fibrillation
- locally advanced